Senior insider sale
Chief Financial Officer at OPUS GENETICS, INC. — senior position signals high conviction
$147.5K
35.78K shares
What this filing means
GAGNON ROBERT E. plans to sell 35.78K shares of OPUS GENETICS, INC. valued at approximately $147.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/3/2026ACC: 0001974158-26-000100
Officer· Chief Financial Officer
Since Sep 2025
35.78K
Shares to sell
$147.5K
Approx. market value
28K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vested Restricted Stock Units
N/A
9/10/2025
28KTotal acquired28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/10/2025 | Vested Restricted Stock Units N/A | 28K | — |
| Total | 28K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.78K
Market value
$22.9K
7/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
28K
Market value
$124.6K
9/3/2026
Total
Units
35.78K
Value
$147.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/23/2026 | 7.78K | $22.9K | — | Completed |
| Planned — Approximate Date | ||||
9/3/2026 | 28K | $124.6K | NASDAQ | Planned |
| Total | 35.78K | $147.5K | ||